We are live on
!
Find out more
RTM
Red Tree Management Portfolio holdings
AUM
$147M
1-Year Est. Return
202.18%
This Fund
S&P 500
This Quarter
Est. Return
+35.01%
1 Year Est. Return
+202.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$147M
AUM Growth
+$35.5M
(+32%)
Cap. Flow
-$156K
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCAX
Bicara Therapeutics
BCAX
|
+$156K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SF
EW
PWAM
KFS
SFP
WC
PIP
NLA
Red Tree Management's Q2 2026 Portfolio in Review
As of Q2 2026, Red Tree Management held 3 positions worth $147M, up 32% from $112M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 0%. Red Tree Management opened no new positions and made no exits, leaving the 3-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Red Tree Management's biggest Q2 2026 reduction was Bicara Therapeutics, cutting an estimated $156K.
- Red Tree Management's ten largest holdings make up 100% of its $147M portfolio in Q2 2026.
- Red Tree Management opened 0 new positions and closed 0 in Q2 2026.
- Red Tree Management's portfolio value rose 32% quarter-over-quarter to $147M.
Based on Red Tree Management's 13F filing for Q2 2026, filed 22 Jul 2026.